Reports from medical professionals highlight "breakthrough" COVID-19 cases occurring in fully vaccinated individuals within two months of their shots. Meanwhile, the Chinese-developed CoronaVac (Sinovac) is being used extensively in Brazil and other nations, with some producers claiming it offers a more traditional and potentially safer alternative to mRNA platforms.
